PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcphysBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Physiology
 
BMC Physiol. 2001; 1: 12.
Published online 2001 August 24.
PMCID: PMC55339
High calcium and dobutamine positive inotropy in the perfused mouse heart: myofilament calcium responsiveness, energetic economy, and effects of protein kinase C inhibition
Guy A MacGowan,corresponding author5 Congwu Du,2,3 and Alan P Koretsky1,3,4
1Pittsburgh NMR Center for Biomedical Research, Carnegie Mellon University, Pittsburgh PA 15213, USA
2Center for Light Microscope Imaging and Biotechnology, Carnegie Mellon University, Pittsburgh PA 15213, USA
3Dept. of Biological Sciences, Carnegie Mellon University, Pittsburgh PA 15213, USA
4Laboratory of Functional and Molecular Imaging. The National Institutes of Neurological Disease and Stroke, Bethesda MD 20892, USA
5Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh PA 15213, USA
corresponding authorCorresponding author.
Guy A MacGowan: macgowanga/at/msx.upmc.edu; Congwu Du: congwu/at/andrew.cmu.edu; Alan P Koretsky: KoretskyA/at/ninds.nih.gov
Received June 12, 2001; Accepted August 24, 2001.
Abstract
Background
In perfused hearts, high calcium-induced inotropy results in less developed pressure relative to myocardial oxygen consumption compared to the β-adrenergic agonist dobutamine. Calcium handling is an important determinant of myocardial oxygen consumption. Therefore, we hypothesized that this phenomenon was due to reduced myofilament responsiveness to calcium, related to protein kinase C activation.
Results
Developed pressure was significantly higher with dobutamine compared to high perfusate calcium of 3.5 mM (73 ± 10 vs 63 ± 10 mmHg, p < 0.05), though peak systolic intracellular calcium was not significantly different, suggesting reduced myofilament responsiveness to intracellular calcium with high perfusate calcium. The ratio of developed pressure to myocardial oxygen consumption, an index of economy of contraction, was significantly increased with dobutamine compared to high perfusate calcium (1.35 ± 0.15 vs 1.15 ± 0.15 mmHg/μmoles/min/g dry wt, p < 0.05), suggesting energetic inefficiency with high perfusate calcium. The specific protein kinase C inhibitor, chelerythrine, significantly attenuated the expected increase in developed pressure when increasing perfusate calcium from 2.5 to 3.5 mM (3.5 mM: 64 ± 8 vs 3.5 mM + chelerythrine: 55 ± 5 mmHg, p < 0.05), though had no effects on dobutamine, or lower levels of perfusate calcium (1.5 to 2.5 mM).
Conclusions
By measuring intracellular calcium, developed pressures and myocardial oxygen consumption in perfused mouse hearts, these results demonstrate that high perfusate calcium positive inotropy compared to dobutamine results in reduced myofilament responsiveness to intracellular calcium, which is associated with energetic inefficiency and evidence of protein kinase C activation.
Articles from BMC Physiology are provided here courtesy of
BioMed Central